Oncolytic viruses: a novel form of immunotherapy
- 1 October 2008
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Anticancer Therapy
- Vol. 8 (10), 1581-1588
- https://doi.org/10.1586/14737140.8.10.1581
Abstract
Oncolytic viruses are novel anticancer agents, currently under investigation in Phase I–III clinical trials. Until recently, most studies have focused on the direct antitumor properties of these viruses, although there is now an increasing body of evidence that the host immune response may be critical to the efficacy of oncolytic virotherapy. This may be mediated via innate immune effectors, adaptive antiviral immune responses eliminating infected cells or adaptive antitumor immune responses. This report summarizes preclinical and clinical evidence for the importance of immune interactions, which may be finely balanced between viral and tumor elimination. On this basis, oncolytic viruses represent a promising novel immunotherapy strategy, which may be optimally combined with existing therapeutic modalities.Keywords
This publication has 71 references indexed in Scilit:
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor ImmunityClinical Cancer Research, 2008
- Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumorsGene Therapy, 2008
- Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of ReovirusClinical Cancer Research, 2008
- Innate Recognition of VirusesImmunity, 2007
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunityClinical and Experimental Immunology, 2006
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyThe Journal of Experimental Medicine, 2006
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Parvovirus H-1-Induced Tumor Cell Death Enhances Human Immune ResponseIn Vitrovia Increased Phagocytosis, Maturation, and Cross-Presentation by Dendritic CellsHuman Gene Therapy, 2005
- A listing of human tumor antigens recognized by T cells: March 2004 updateCancer Immunology, Immunotherapy, 2004